4//SEC Filing
Aralez Pharmaceuticals Inc. 4
Accession 0001104659-16-129270
CIK 0001660719operating
Filed
Jun 23, 8:00 PM ET
Accepted
Jun 24, 4:31 PM ET
Size
4.9 KB
Accession
0001104659-16-129270
Insider Transaction Report
Form 4
Glickman Mark A
Chief Commercial Officer
Transactions
- Tax Payment
Common Shares, without par value
2016-06-22$3.34/sh−10,803$36,082→ 175,750 total
Footnotes (1)
- [F1]This represents shares withheld by the Issuer for payment of withholding tax liability incurred upon the vesting of 28,999 restricted stock units, 7,284 of which were previously granted on June 22, 2015 and 21,715 of which were previously granted on February 12, 2016, all of which vested on June 22, 2016.
Documents
Issuer
Aralez Pharmaceuticals Inc.
CIK 0001660719
Entity typeoperating
IncorporatedBritish Columbia, Canada
Related Parties
1- filerCIK 0001660719
Filing Metadata
- Form type
- 4
- Filed
- Jun 23, 8:00 PM ET
- Accepted
- Jun 24, 4:31 PM ET
- Size
- 4.9 KB